VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $29,144,000 | +674.9% | 1,064,435 | +1026.4% | 2.12% | +4402.1% |
| Q1 2022 | $3,761,000 | +30.5% | 94,499 | +5.0% | 0.05% | -75.3% |
| Q4 2021 | $2,882,000 | +17.3% | 89,967 | +8.0% | 0.19% | +11.8% |
| Q3 2021 | $2,456,000 | -11.7% | 83,331 | +1.9% | 0.17% | -12.8% |
| Q2 2021 | $2,780,000 | -0.3% | 81,812 | -4.6% | 0.20% | -8.9% |
| Q1 2021 | $2,787,000 | +13.6% | 85,753 | +25.9% | 0.21% | +6.5% |
| Q4 2020 | $2,453,000 | -11.2% | 68,103 | -3.5% | 0.20% | -20.6% |
| Q3 2020 | $2,762,000 | -90.0% | 70,542 | -90.6% | 0.25% | -90.0% |
| Q2 2020 | $27,583,000 | +60.0% | 751,987 | +0.5% | 2.53% | -10.0% |
| Q1 2020 | $17,243,000 | +121.3% | 748,379 | +181.2% | 2.81% | +125.3% |
| Q4 2019 | $7,791,000 | +1707.7% | 266,093 | +1550.4% | 1.25% | +1851.6% |
| Q3 2019 | $431,000 | – | 16,123 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |